In the Media

Axios reporter Bryan Walsh writes that Broad Institute researchers have developed a CRISPR-based diagnostic tool that tests for different pathogens simultaneously. “The new technology could help speed COVID-19 tests, but its bigger impact could be in enabling clinicians to rapidly test a patient sample for more than 150 different viruses."